Table 6. Delay in days and proportion (%) of patients seen within 3 months and delay of >3, 6 and 12 months for all cancer diagnoses/site in the radiotherapy waiting time study, Zaria 2010–2014.
| Intervals | Diagnosis-to consultation (WT1) |
Consultation-to Radiotherapy (WT2) |
Decision-to-Treat to Radiotherapy (WT3) |
Diagnosis-to Radiotherapy (WT4) |
|---|---|---|---|---|
| Median (IQR) days | 40 (17–155) | 131 (14–212) | 131 (14–212) | 213 (102–354) |
| % of patients seen within 3 months | 65% | 46% | 48% | 23% |
| % of patients with >3 months delay | 12% | 23% | 24% | 18% |
| % of patients with >6 months delay | 13% | 24% | 23% | 35% |
| % of patients with >1 year delay | 10% | 7% | 7% | 24% |